MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jnci/djaf060

Медицинская библиотека · Journal of the National Cancer Institute · 2025

Determinants of late metastases in renal cell carcinoma.

Kapur Payal, Zhong Hua, Christie Alana, Xu Haitao, Cai Qi, Araj Ellen, Kim David, Miyata Jeffrey, Tcheuyap Vanina T, Ball Colleen T, Thiel David D, Parker Alexander, Antwi Samuel O, Leibovich Brad C, Modrusan Zora, Cheville John C, Brugarolas James

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The mechanisms underlying metastatic latency in renal cell carcinoma (RCC) remain poorly understood.

METHODS

This study evaluated 2 large independent cohorts for differences in tumor biology between patients who developed metastases early (≤1 year after nephrectomy) and those with late onset (>3 years).

RESULTS

In the discovery cohort (n = 161), late metastatic RCC was associated with clear cell histology (88.9% vs 78.7%), lower pathological stage (pT1-2; 40.3% vs 18.0%), and favorable histopathological features including low grade (40.0% vs 2.3%), less sarcomatoid (5.6% vs 21.8%), and reduced necrosis (37.7% vs 78.3%; all P < .02). Late metastatic RCC tumors exhibited increased angiogenesis (63.5% vs 19.4%) and reduced inflammation (78.8% vs 50.0%; all P < .02) profiles. Genomic driver analyses revealed comparable rates of PBRM1 and SETD2 loss in late and early metastatic RCC, while BAP1 loss was significantly less common in late metastatic RCC (7.5% vs 27.1%; P < .02). In multivariable models, BAP1/PBRM1/SETD2 status and tumor necrosis emerged as key discriminators of late metastatic RCCs. These findings were confirmed in the second cohort (n = 307). Late metastatic RCC was enriched for fatty acid oxidation and angiogenesis pathways, supporting a less aggressive phenotype. This was further evidenced by a lower engraftment rate in murine models (0% vs 36.5%; P < .001) and significantly longer overall survival from the time of metastasis (median survival doubled, P < .001). Interestingly, late metastatic RCC shared genomic and phenotypic features with RCC that metastasizes to the pancreas, suggesting a common underlying biology influencing both metastatic latency and pancreatic tropism.

CONCLUSIONS

Overall, these findings advocate for recognition of late metastatic RCC because of its distinct biology and improved prognosis.

Для цитирования: Kapur Payal, Zhong Hua, Christie Alana, Xu Haitao, Cai Qi, Araj Ellen, Kim David, Miyata Jeffrey, Tcheuyap Vanina T, Ball Colleen T, Thiel David D, Parker Alexander, Antwi Samuel O, Leibovich Brad C, Modrusan Zora, Cheville John C, Brugarolas James. Determinants of late metastases in renal cell carcinoma.. Journal of the National Cancer Institute. 2025. DOI: 10.1093/jnci/djaf060.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.